Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISTH 2022 | Offering personalized therapy to young and elderly patients with non-severe hemophilia

Oliver Königsbrügge, MD, PhD, Medical University of Vienna, Vienna, Austria, emphasizes the importance of selecting appropriate treatments for both young and elderly patients with non-severe hemophilia, commenting on the role of age in treatment decisions. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.